From: Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs
Alveolar lipoproteinosis | Mixed cell alveolar inflammation | ||||||
---|---|---|---|---|---|---|---|
PBS | DQ12 | DQ12-PVNO | PBS | DQ12 | DQ12-PVNO | ||
3d | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 3d | 0.0 ± 0.0 | 1.2 ± 0.7* | 0.0 ± 0.0# |
7d | 0.0 ± 0.0 | 0.2 ± 0.4 | 0.0 ± 0.0 | 7d | 0.0 ± 0.0 | 1.1 ± 0.7* | 0.5 ± 0.6 |
28d | 0.0 ± 0.0 | 1.0 ± 0.3** | 0.3 ± 0.4## | 28d | 0.0 ± 0.0 | 0.8 ± 1.1 | 0.0 ± 0.0 |
90d | 0.0 ± 0.0 | 1.3 ± 0.8* | 0.0 ± 0.0# | 90d | 0.0 ± 0.0 | 0.5 ± 0.4 | 0.1 ± 0.2 |
180d | 0.0 ± 0.0 | 2.0 ± 0.4** | 0.3 ± 0.4## | 180d | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
360d | 0.0 ± 0.0 | 2.6 ± 1.5** | 2.9 ± 1.5$$ | 360d | 0.0 ± 0.0 | 0.6 ± 1.0 | 0.0 ± 0.0 |
Alveolar histocytosis | Brochoalveolar hyperplasia | ||||||
PBS | DQ12 | DQ12-PVNO | PBS | DQ12 | DQ12-PVNO | ||
3d | 0.0 ± 0.0 | 0.8 ± 0.7 | 0.1 ± 0.3 | 3d | 0.0 ± 0.0 | 0.7 ± 0.9 | 0.3 ± 0.7 |
7d | 0.3 ± 0.7 | 1.5 ± 0.7 | 0.5 ± 0.4# | 7d | 0.9 ± 1.8 | 2.2 ± 1.4 | 0.6 ± 0.8 |
28d | 1.0 ± 0.4 | 3.4 ± 1.4* | 1.4 ± 0.8# | 28d | 1.0 ± 0.4 | 3.1 ± 1.8 | 1.4 ± 1.2 |
90d | 0.4 ± 0.7 | 3.8 ± 0.6** | 1.0 ± 0.7## | 90d | 0.8 ± 1.0 | 2.6 ± 1.4 | 0.6 ± 0.3 |
180d | 0.8 ± 0.4 | 2.4 ± 0.6* | 2.5 ± 1.0 $ | 180d | 0.1 ± 0.3 | 2.3 ± 1.0** | 2.3 ± 0.7 $$ |
360d | 0.3 ± 0.3 | 3.0 ± 0.6** | 2.0 ± 0.4 $$,# | 360d | 0.0 ± 0.0 | 5.5 ± 1.1** | 3.9 ± 1.0 $$,# |
Fibrosis alveolar septa | Perivascular fibrosis | ||||||
PBS | DQ12 | DQ12-PVNO | PBS | DQ12 | DQ12-PVNO | ||
3d | 0.0 ± 0.0 | 0.1 ± 0.3 | 0.0 ± 0.0 | 3d | 1.0 ± 0.2 | 1.0 ± 0.0 | 0.9 ± 0.2 |
7d | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 7d | 0.6 ± 0.2 | 1.0 ± 0.0* | 1.0 ± 0.0 |
28d | 0.0 ± 0.0 | 0.4 ± 0.6 | 0.0 ± 0.0 | 28d | 1.1 ± 0.2 | 1.3 ± 0.4 | 1.1 ± 0.2 |
90d | 0.0 ± 0.0 | 1.0 ± 0.8* | 0.0 ± 0.0# | 90d | 1.0 ± 0.0 | 1.4 ± 0.4 | 1.0 ± 0.0 |
180d | 0.2 ± 0.2 | 1.4 ± 1.3 | 0.4 ± 0.4 | 180d | 0.8 ± 0.2 | 1.6 ± 0.2** | 1.5 ± 0.4 $ |
360d | 0.7 ± 0.5 | 2.1 ± 0.2** | 1.3 ± 0.5# | 360d | 1.1 ± 0.4 | 2.3 ± 0.2** | 1.9 ± 0.4 $ |